非酒精性脂肪性肝病对美国人群死亡归因分数的27年随访研究
基于第三次美国国家健康与营养调查中12,253名经超声评估NAFLD的成人,随访至2015年。NAFLD与全因死亡风险增加20%相关(HR 1.20,95%CI 1.08–1.34),全因死亡PAF为7.5%,糖尿病相关死亡PAF为38.0%,男性肝病相关死亡PAF达68.3%。
要点
- NAFLD与全因死亡风险增加20%独立相关(HR 1.20,95%CI 1.08–1.34)。
- 全因死亡归因分数为7.5%,糖尿病相关死亡归因分数达38.0%。
- 男性肝病相关死亡归因分数高达68.3%,显著高于女性。
核心结论
- 在美国,约8%的全因死亡及超过三分之一的肝病和糖尿病相关死亡与NAFLD相关。
研究设计与样本
- 基于第三次美国国家健康与营养调查(NHANES III)的队列分析,纳入12,253名经超声评估NAFLD的成人,随访至2015年。
- 采用Cox比例风险回归估计多变量校正风险比(HR)及95%置信区间,并计算性别和种族/民族特异性人群归因分数(PAF)。
主要发现
- NAFLD与全因死亡风险增加20%相关(HR 1.20;95%CI 1.08–1.34)。
- 全因死亡总体PAF为7.5%(95%CI 3.0–12.0)。
- 糖尿病相关死亡PAF总体为38.0%(95%CI 13.1–63.0),男性40.8%(95%CI 2.1–79.6),女性36.8%(95%CI 6.6–67.0)。
- 肝病相关死亡PAF男性为68.3%(95%CI 36.3–100.0),女性为3.5%(95%CI -39.7–46.8)。
- 仅白人群体中全因死亡PAF(9.3%;95%CI 4.0–14.6)和糖尿病相关死亡PAF(44.4%;95%CI 10.8–78.0)显著大于零。
临床怎么用
- 在消化内科评估NAFLD患者时,应关注其全因死亡及糖尿病相关死亡风险增加。
- 男性NAFLD患者肝病相关死亡归因分数极高,需加强肝病进展监测与干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Nonalcoholic fatty liver disease (NAFLD) encompasses a range of conditions, from simple steatosis to nonalcoholic steatohepatitis. Studies in the United States have reported an increased mortality risk among individuals with NAFLD; therefore, the population attributable fractions (PAFs) for mortality were examined. APPROACH AND RESULTS: A total of 12,253 adult individuals with ultrasound assessment of NAFLD from the Third National Health and Nutrition Examination Survey and mortality follow-up through 2015 were included in the analysis. Cox proportional hazard regression was used to estimate multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for NAFLD in association with all-cause and cause-specific mortality. Overall, sex- and race/ethnicity-specific PAFs and 95% CIs were estimated. In the current study, presence of NAFLD was associated with a 20% increased risk of all-cause mortality (HR, 1.20; 95% CI, 1.08, 1.34). The overall PAF for all-cause mortality associated with NAFLD was 7.5% (95% CI, 3.0, 12.0). The PAF for diabetes-specific mortality was 38.0% (95% CI, 13.1, 63.0) overall, 40.8% (95% CI, 2.1, 79.6) in men, and 36.8% (95% CI, 6.6, 67.0) in women. The PAF for liver disease (LD)-specific mortality was notably higher in men (68.3%; 95% CI, 36.3, 100.0) than women (3.5%; 95% CI, -39.7, 46.8). In the race-specific analysis, the PAFs of NAFLD for all-cause mortality (9.3%; 95% CI, 4.0, 14.6) and diabetes-specific mortality (44.4%; 95% CI, 10.8, 78.0) were significantly greater than zero only for whites. CONCLUSIONS: In the United States, approximately 8% of all-cause mortality and more than one-third of LD- and diabetes-specific deaths are associated with NAFLD. With these high percentages, efforts are needed to reduce the burden of NAFLD in the United States.
引用
- Alvarez CS, Graubard BI, Thistle JE, et al. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow-up. Hepatology. 2020. PMID: 31733165. doi:10.1002/hep.31040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。